HUE062353T2 - Eljárás terc-butil-(N-((1R,2S,5S)-2-((2-((5-klórpiridin-2-il)amino)-2-oxoacetil)amino)-5 -(dimetilkarbamoil)ciklohexil)karbamát) elõállítására - Google Patents

Eljárás terc-butil-(N-((1R,2S,5S)-2-((2-((5-klórpiridin-2-il)amino)-2-oxoacetil)amino)-5 -(dimetilkarbamoil)ciklohexil)karbamát) elõállítására

Info

Publication number
HUE062353T2
HUE062353T2 HUE19706921A HUE19706921A HUE062353T2 HU E062353 T2 HUE062353 T2 HU E062353T2 HU E19706921 A HUE19706921 A HU E19706921A HU E19706921 A HUE19706921 A HU E19706921A HU E062353 T2 HUE062353 T2 HU E062353T2
Authority
HU
Hungary
Prior art keywords
amino
oxoacetyl
chloropyridin
dimethylcarbamoyl
carbamate
Prior art date
Application number
HUE19706921A
Other languages
English (en)
Inventor
Garcia Elena Garcia
Rodriguez Alicia Dobarro
Original Assignee
Moehs Iberica Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65520240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE062353(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Moehs Iberica Sl filed Critical Moehs Iberica Sl
Publication of HUE062353T2 publication Critical patent/HUE062353T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
HUE19706921A 2018-02-14 2019-02-13 Eljárás terc-butil-(N-((1R,2S,5S)-2-((2-((5-klórpiridin-2-il)amino)-2-oxoacetil)amino)-5 -(dimetilkarbamoil)ciklohexil)karbamát) elõállítására HUE062353T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201830131A ES2722854B2 (es) 2018-02-14 2018-02-14 Procedimiento para preparar n-((1r,2s,5s)-2-((2-((5-cloropiridin-2-il)amino)-2-oxoacetil)amino)-5-(dimetilcarbamoil) ciclohexil)carbamato de terc-butilo

Publications (1)

Publication Number Publication Date
HUE062353T2 true HUE062353T2 (hu) 2023-10-28

Family

ID=65520240

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE19706921A HUE062353T2 (hu) 2018-02-14 2019-02-13 Eljárás terc-butil-(N-((1R,2S,5S)-2-((2-((5-klórpiridin-2-il)amino)-2-oxoacetil)amino)-5 -(dimetilkarbamoil)ciklohexil)karbamát) elõállítására

Country Status (8)

Country Link
EP (1) EP3752488B1 (hu)
JP (1) JP7327736B2 (hu)
CA (1) CA3087004A1 (hu)
ES (2) ES2722854B2 (hu)
HU (1) HUE062353T2 (hu)
PT (1) PT3752488T (hu)
SI (1) SI3752488T1 (hu)
WO (1) WO2019158550A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111763222B (zh) * 2020-08-03 2021-05-25 珠海市海瑞德新材料科技有限公司 用于制备依度沙班游离碱的中间体及其制备方法和应用
WO2023223346A1 (en) 2022-05-16 2023-11-23 Mylan Laboratories Limited An improved process for the preparation of edoxaban intermediate
CN114736218A (zh) * 2022-05-24 2022-07-12 哈药集团技术中心 一种甲苯磺酸艾多沙班一水合物的制备方法
WO2024009206A1 (en) * 2022-07-04 2024-01-11 Ami Lifesciences Private Limited A process for the preparation of edoxaban and its intermediates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159438A0 (en) 2001-06-20 2004-06-01 Daiichi Seiyaku Co Diamine derivatives
ES2569398T3 (es) * 2005-09-16 2016-05-10 Daiichi Sankyo Company, Limited Derivado de diamina ópticamente activo y proceso para producir el mismo
CN102348688B (zh) * 2009-03-10 2014-07-09 第一三共株式会社 用于制备二胺衍生物的方法
CN102348680B (zh) * 2009-03-13 2014-11-05 第一三共株式会社 用于制备光学活性二胺衍生物的方法
HUE031961T2 (hu) * 2010-07-02 2017-09-28 Daiichi Sankyo Co Ltd Eljárás optikailag aktív diaminszármazék só elõállítására
TWI571460B (zh) * 2016-03-14 2017-02-21 中化合成生技股份有限公司 二胺衍生物之製造方法
EP3484893A1 (en) * 2016-07-13 2019-05-22 Mylan Laboratories Ltd. Salt of amine-protected (1s,2r,4s)-1,2-amino-n,n-dimethylcyclohexane-4-carboxamide
CN107641131B (zh) * 2016-07-22 2019-06-18 江苏威凯尔医药科技有限公司 一种抗血栓药物的制备方法

Also Published As

Publication number Publication date
ES2942034T3 (es) 2023-05-29
EP3752488B1 (en) 2023-03-08
SI3752488T1 (sl) 2023-07-31
EP3752488A1 (en) 2020-12-23
PT3752488T (pt) 2023-05-12
ES2722854B2 (es) 2019-12-20
JP2021514348A (ja) 2021-06-10
ES2722854A1 (es) 2019-08-19
JP7327736B2 (ja) 2023-08-16
CA3087004A1 (en) 2019-08-22
WO2019158550A1 (en) 2019-08-22

Similar Documents

Publication Publication Date Title
PT3752488T (pt) Método de preparação de n-((1r,2s,5s)-2-((2-((5- cloropiridin-2-il)amino)-2-oxoacetil)amino)-5- (dimetilcarbamoil)ciclo-hexil)carbamato de terc-butilo
IL276779A (en) Derivatives and related compounds of n-(phenyl)-2-(phenyl)pyrimidine-4-carboxamide as hpk1 inhibitors for cancer treatment
PL3606909T3 (pl) Sól sodowa N-((1,2,3,5,6,7-heksahydro-s-indacen-4-ylo)karbamoilo)-1-izopropylo-1H-pirazolo-3-sulfonamidu
BR112017004673A2 (pt) formas cristalinas de 2-(4-(4-etoxi-6-oxo-1,6-diidropiridin-3-ila)-2-fluorofenil)-n-(5-(1,1,1-trifluoro-2-metilpropan-2-il)isoxazol-3-il) acetamida
MX2017015921A (es) Metodos para tratar esclerosis multiple.
EP3263553A4 (en) Crystalline modification of n-(2-(3-phenylureido)phenyl)benzenesulfonamide and recording material using same
PH12020500211A1 (en) Methods of treating behavior alterations
UY34722A (es) Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil] etil}amino)-1-hidroxietil]-8- hidroxiquinolin-2(1h)-ona
SI3658552T1 (sl) Postopek za pripravo N-(5-((4-(4-((dimetilamino)metil)-3-fenil-1H-pirazol-1-il)pirimidin-2-il )amino)-4-metoksi-2-morfolinofenil)akrilamida z reagiranjem ustreznega amina s 3-halo-propionil kloridom
RS64545B1 (sr) Postupak za pripremu n-(5-(4-(4-formil-3-fenil-1h-pirazol-1-il)pirimidin-2-ilamino)-4-metoksi-2-morfolinofenil)akrilamida
EP3856174A4 (en) HDAC1, 2 INHIBITORS
EP3724163A4 (en) FLUORINE DERIVATIVES 4- (AMINO SUBSTITUTE) PHENYL CARBAMATE
IL304486A (en) Method for preparing tert-butyl n-((s5,s2,r1)-2-((2-((chloropyridin-2-yl)amino)-2-oxoacetyl)amino)-5-(dimethylcarbamoine)cyclohexyl)carbamate
EP4069228A4 (en) PROCESS FOR PREPARING 2-(4-CHLORPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUORACETAMIDE
ZA201600006B (en) Polymorphic forms of methyl((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl)carbamate and salts thereof
SI3655395T1 (sl) Postopek za pripravo N-((1R,2S,SR)-5-(TERT-butilamino)-2-((S)-3-(7- TERT-butilpirazolo(1,5-A)(1,3,5)triazin-4-ilamino)-2-oksopirolidin-1-il) cikloheksil) acetamida
EP3818042A4 (en) METHODS FOR PREPARING COMPOUNDS (E)-(2-(CHLOROMETHYL)-3-FLUOROALLYL)CARBAMATES
EP3259267A4 (en) A NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R, 5R) -5 - {[(2S) -2 - [(METHYL {[2- (PROPAN-2-YL) -1) CARBAMATE 3-thiazol-4-yl] methyl} carbamoyl) amino] -4- (morpholin-4-yl) butanoyl] amino} -1,6-DIPHÉNYLHEXAN-2-YL]
SI3164385T1 (sl) Nova polimorfna oblika N-(2-(6-fluoro-LH-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoksi) benzilamin hidroklorida za zdravljenje Alzheimerjeve bolezni
EA201891948A1 (ru) Отрицательные аллостерические модуляторы метаботропного глутаматного рецептора 5 для применения в лечении зрелых повреждений головного мозга
BR112022004455A2 (pt) Processos para a preparação de n-(5-((5r,6s)-5-amino-6-fluoro-oxepan-2-il)-1-metil-1h-pirazol-4-il)-2-(2,6-difluorofenil)tiazol-4-carboxamida e para a preparação de (3s,4r)-3-fluoro-7-(1-metil-4-nitro-1h-pirazol-5-il)oxepan-4-amina
PL3334707T3 (pl) Sposób wytwarzania związku stanowiącego n-(3,5-dimetylofenylo)-n'-(2-trifluorometylofenylo)guanidynę
UY36585A (es) Proceso de preparación
UA94667U (uk) Заміщені [2-(3-r-1h-[1,2,4]триазол-5-іл)феніл]аміни, що проявляють гіпоглікемічну активність